Alger appeared to be the VC, which was created in 1964. The venture was found in North America in United States. The main office of represented VC is situated in the New York.
We also calculated 7 valuable employees in our database.
Opposing the other organizations, this Alger works on 4 percentage points less the average amount of lead investments. The fund is constantly included in less than 2 investment rounds annually. The higher amount of exits for fund were in 2016. The top activity for fund was in 2014. Deals in the range of 50 - 100 millions dollars are the general things for fund. The average startup value when the investment from Alger is more than 1 billion dollars. Considering the real fund results, this VC is 55 percentage points more often commits exit comparing to other organizations.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Alger, startups are often financed by Venrock, New Leaf Venture Partners, New Enterprise Associates. The meaningful sponsors for the fund in investment in the same round are RA Capital Management, Quadrille Capital, New Leaf Venture Partners. In the next rounds fund is usually obtained by The Pritzker Organization, The Baupost Group, Silicon Valley Bank.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Medical Device, Advertising. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Intarcia Therapeutics, ChoiceStream, Tolero Pharmaceuticals.
Funds with similar focus
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Tolero Pharmaceuticals | $8M | 05 Nov 2014 | Salt Lake City, Utah, United States | ||
Tolero Pharmaceuticals | $14M | 07 Aug 2014 | Salt Lake City, Utah, United States | ||
| $7M | 28 Jul 2014 | Boston, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Tolero Pharmaceuticals | $8M | 05 Nov 2014 | Salt Lake City, Utah, United States | ||
Tolero Pharmaceuticals | $14M | 07 Aug 2014 | Salt Lake City, Utah, United States | ||
| $7M | 28 Jul 2014 | Boston, Massachusetts, United States |
